CreatorsPublishersAdvertisers
View more in
Medical & Biotech

With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised

FiercePharma
 2021-07-30

Cover picture for the articleWith its rapid mutations, the evolutionary process of the coronavirus makes it a moving target. And so it is with treatments for the disease, which can quickly become in vogue or obsolete. Case in point for the former: Regeneron’s antibody cocktail REGEN-COV. Over the last few months, nearly every development...

www.fiercepharma.com

Comments / 0

Comments / 0